TABLE 2.
FA analysis of Raji B cells1
| FAs | BSA | EPA | DHA |
| 14:0 | 0.6 ± 0.4 | 0.8 ± 0.1 | 1.1 ± 0.1 |
| 16:0 | 19.4 ± 1.5 | 14.4 ± 0.7* | 17.7 ± 0.4 |
| 16:1 | 3.3 ± 0.5 | 2.6 ± 0.1 | 2.5 ± 0.0 |
| 18:0 | 16.7 ± 1.0 | 13.0 ± 0.2** | 1.1 ± 0.1** |
| cis 18:1 | 38.1 ± 1.5 | 23.1 ± 1.5*** | 22.2 ± 1.0*** |
| 18:2(n–6) | 3.6 ± 0.2 | 2.3 ± 0.0*** | 2.2 ± 0.1*** |
| 20:4(n–6) | 9.3 ± 0.9 | 5.4 ± 0.1** | 5.3 ± 0.3** |
| 20:5(n–3) | 0.6 ± 0.0 | 25.1 ± 0.7*** | 1.1 ± 0.2 |
| 22:5(n–3) | 4.0 ± 0.4 | 12.3 ± 0.6*** | 2.0 ± 0.1* |
| 22:6(n–3) | 4.4 ± 0.4 | 2.2 ± 0.1 | 33.0 ± 1.1*** |
| ∑ SFAs | 36.7 ± 1.3 | 26.9 ± 1.0*** | 31.7 ± 0.3* |
| ∑ MUFAs | 41.4 ± 1.8 | 25.8 ± 1.5*** | 24.7 ± 1.0*** |
| ∑ (n–3) PUFAs | 8.9 ± 0.9 | 39.5 ± 0.8*** | 36.1 ± 1.0*** |
| ∑ (n–6) PUFAs | 12.9 ± 1.1 | 7.8 ± 0.1** | 7.5 ± 0.3** |
1
B cells were treated with BSA or 25 μmol EPA or DHA/L for 24 h. Data are means ± SEMs from 5 independent experiments. Values (arbitrary units) are percentage of total FAs. Asterisks indicate statistical significance relative to the BSA control: *P < 0.05, **P < 0.01, and ***P < 0.001.